Cang S - Search Results

1

Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection.

Li B, Liu J, Wu G, Zhu Q, Cang S. Li B, et al. Among authors: cang s. Front Surg. 2023 Jan 6;9:905437. doi: 10.3389/fsurg.2022.905437. eCollection 2022. Front Surg. 2023. PMID: 36684123 Free PMC article.

2

P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia.

Cang S, Liu D. Cang S, et al. J Hematol Oncol. 2008 Oct 1;1:15. doi: 10.1186/1756-8722-1-15. J Hematol Oncol. 2008. PMID: 18828913 Free PMC article. Review.

3

t(3;9;22) 3-way chromosome translocation in chronic myeloid leukemia is associated with poor prognosis.

Tan J, Cang S, Seiter K, Primanneni S, Ahmed N, Mathews T, Liu D. Tan J, et al. Among authors: cang s. Cancer Invest. 2009 Aug;27(7):718-22. doi: 10.1080/07357900802653498. Cancer Invest. 2009. PMID: 19308813 Review.

4

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer.

Cang S, Ma Y, Liu D. Cang S, et al. J Hematol Oncol. 2009 Jun 1;2:22. doi: 10.1186/1756-8722-2-22. J Hematol Oncol. 2009. PMID: 19486511 Free PMC article. Review.

5

[A cohort study on the relationship between vegetable intake and risks of lung cancer in the Tin Corporation (YTC) miners in Yunnan].

Lu Q, Yao S, Huang C, Lan Y, Cang S, Qiao Y, Wang R. Lu Q, et al. Among authors: cang s. Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Jun;21(3):205-7. Zhonghua Liu Xing Bing Xue Za Zhi. 2000. PMID: 11860786 Chinese.

6

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents.

Tan J, Cang S, Ma Y, Petrillo RL, Liu D. Tan J, et al. Among authors: cang s. J Hematol Oncol. 2010 Feb 4;3:5. doi: 10.1186/1756-8722-3-5. J Hematol Oncol. 2010. PMID: 20132536 Free PMC article. Review.

7

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.

Guo LH, Zhang MF, Zhang HL, Zhou JY, Cai XH, Long Y, Guo QS, Yang N, Zhao J, Xie ZH, Jiang B, Zhu Y, Fan Y, Xie CY, Hu Y, Yao Y, Jia J, Li XL, Cui JW, Sui XZ, Lin W, Cheng Y, Wang HJ, Wang CL, Zhao MF, Qiao GB, Peng LJ, Yang L, Chen GY, Cai KC, Xu XH, Zhang LM, Feng GS, Zhou JM, Wu GW, Dong XR, Wang LF, Zhang HM, Gao YJ, Jiang QY, Cang SD, Yang ZX, Song X, Liu XQ, Zhu B, Chen FX, Hu CH, Chen X, Wu YL, Zhou Q. Guo LH, et al. Front Oncol. 2020 Sep 15;10:1568. doi: 10.3389/fonc.2020.01568. eCollection 2020. Front Oncol. 2020. PMID: 33042801 Free PMC article.

8

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis.

Yan J, Wu X, Yu J, Zhu Y, Cang S. Yan J, et al. Among authors: cang s. Front Oncol. 2020 Nov 10;10:570654. doi: 10.3389/fonc.2020.570654. eCollection 2020. Front Oncol. 2020. PMID: 33240814 Free PMC article.

9

Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data.

Zhu Y, Cang S, Chen B, Gu Y, Jiang M, Yan J, Shao F, Huang X. Zhu Y, et al. Among authors: cang s. Front Oncol. 2020 Dec 4;10:526577. doi: 10.3389/fonc.2020.526577. eCollection 2020. Front Oncol. 2020. PMID: 33344220 Free PMC article.

10

Yan J, Wu X, Yu J, Kong Y, Cang S. Yan J, et al. Among authors: cang s. Front Immunol. 2022 Feb 24;13:839901. doi: 10.3389/fimmu.2022.839901. eCollection 2022. Front Immunol. 2022. PMID: 35280982 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters